NCT00008190View on ClinicalTrials.gov

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 1999

Primary Completion Date

November 30, 2005

Study Completion Date

May 31, 2008

Conditions
Leukemia
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

filgrastim

DRUG

busulfan

DRUG

cyclophosphamide

DRUG

etoposide

DRUG

melphalan

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

10032

Herbert Irving Comprehensive Cancer Center at Columbia University, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Herbert Irving Comprehensive Cancer Center

OTHER

NCT00008190 - Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia | Biotech Hunter | Biotech Hunter